FeaturedNeurologyNeuroscience·July 11, 2025·5 min readCommon Pain Medication Linked to Cognitive Decline RiskA large U.S. medical records study has found that adults prescribed gabapentin six or more times for chronic low back pain face significantly higher risks of dementia (29%) and mild cognitive impairment (85%) within 10 years. The risks were especially pronounced in younger adults aged 35–64, where rates of cognitive decline more than doubled or tripled compared to those not on the drug.Read More
FeaturedNeurosciencePsychology·June 25, 2025·4 min readAutoimmune Disease Doubles Risk of Depression and AnxietyPeople living with autoimmune diseases face nearly twice the risk of developing persistent mental health disorders like depression, anxiety, and bipolar disorder, according to a massive UK-based study. Researchers suggest chronic inflammation may play a key role in this connection, especially in women who showed significantly higher risk levels than men.Read More
FeaturedNeurosciencePsychology·June 4, 2025·5 min readLow-Calorie Diets May Increase Depression RiskNew research links low-calorie diets with a slight increase in depressive symptoms, particularly among overweight individuals and men. The large observational study analyzed dietary habits and depression scores in over 28,000 U.S. adults.Read More
FeaturedNeurologyNeuroscience·May 21, 2025·4 min readCold Sore Virus Linked to Alzheimer’s, Antivirals May Lower RiskA large study suggests that symptomatic infection with herpes simplex virus 1 (HSV-1)—best known for causing cold sores—may significantly raise the risk of developing Alzheimer’s disease. Researchers found that people with HSV-1 were 80% more likely to have Alzheimer’s, while those treated with antiviral medications had a 17% lower risk.Read More
FeaturedNeurologyNeuroscience·September 25, 2024·3 min readAlzheimer’s Drug Faces Scrutiny Over Safety, Efficacy ConcernsThe FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an investigation. The study highlights multiple patient deaths during trials, design flaws, and the financial ties of panelists who recommended the drug's approval.Read More
FeaturedNeurosciencePsychology·August 21, 2024·3 min readHigh-Dose Psilocybin Shows Potential as an Antidepressant TreatmentA meta-analysis suggests that high doses of psilocybin may alleviate depressive symptoms similarly to the SSRI drug escitalopram. While the effect size was small, psilocybin outperformed placebo in clinical trials, though study design flaws could have led to overestimated results. The findings indicate that psilocybin, particularly in high doses, may offer a new avenue for treating depression, comparable to existing antidepressants.Read More
FeaturedNeuroscience·July 17, 2024·6 min readNighttime Exercise Breaks May Extend Sleep by 27 MinutesA new suggests that three-minute resistance exercise breaks every 30 minutes in the evening can extend sleep duration by an average of 27 minutes. This practice doesn't disrupt sleep quality and could reduce cardiometabolic disease risk. Participants engaged in simple exercises like chair squats and calf raises. Further research is needed to confirm these findings in real-life settings.Read More
FeaturedNeurosciencePsychology·May 2, 2024·7 min readPsilocybin Effective as AntidepressantPsilocybin, the psychoactive compound in magic mushrooms, is notably more effective at alleviating depression symptoms than conventional controls. Analyzing seven trials with 436 participants, researchers found a substantial improvement in depression scores following psilocybin treatment compared to placebos or other minor psychedelic doses, showcasing a large effect size.Read More
FeaturedNeurologyNeurosciencePsychology·April 20, 2024·7 min readRisks of Antipsychotic Use in Dementia PatientsA new study revealed significant risks associated with antipsychotic use in dementia patients, including increased chances of stroke, heart failure, pneumonia, and other serious conditions. The research analyzed data from 173,910 dementia patients in England, tracking those prescribed antipsychotics post-diagnosis against those who were not.Read More
Brain CancerFeaturedNeurologyNeuroscience·March 28, 2024·4 min readProlonged Progestogen Use Linked to Brain Tumor RiskA new study highlights a significant link between prolonged use of certain progestogen hormone drugs and an increased risk of developing intracranial meningioma, a type of brain tumor. Researchers analyzed data from 18,061 women who underwent surgery for intracranial meningioma, comparing their progestogen use to 90,305 controls.Read More
FeaturedNeurosciencePsychology·January 18, 2024·6 min readOCD Linked to Higher Mortality RisksA new study highlights a concerning link between obsessive-compulsive disorder (OCD) and an increased risk of death from both natural and unnatural causes. The study, using data from over 60,000 people with OCD, shows an 82% higher overall mortality risk compared to those without the disorder.Read More
Auditory NeuroscienceFeaturedNeuroscience·January 16, 2024·5 min readLoud Play, Silent Risk: Video Gaming’s Link to Hearing LossA systematic review indicates a potential risk of irreversible hearing loss and tinnitus among video gamers due to high sound levels. The study, encompassing over 50,000 individuals, found that sound levels in gaming often near or exceed safe limits.Read More
